202 related articles for article (PubMed ID: 12503000)
1. Spinal nitric oxide contributes to the analgesic effect of intrathecal [d-pen2,d-pen5]-enkephalin in normal and diabetic rats.
Chen SR; Pan HL
Anesthesiology; 2003 Jan; 98(1):217-22. PubMed ID: 12503000
[TBL] [Abstract][Full Text] [Related]
2. Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain.
Chen SR; Khan GM; Pan HL
Anesthesiology; 2001 Oct; 95(4):1007-12. PubMed ID: 11605898
[TBL] [Abstract][Full Text] [Related]
3. Role of spinal nitric oxide in the inhibitory effect of [D-Pen2, D-Pen5]-enkephalin on ascending dorsal horn neurons in normal and diabetic rats.
Khan GM; Li DP; Chen SR; Pan HL
J Pharmacol Exp Ther; 2002 Dec; 303(3):1021-8. PubMed ID: 12438523
[TBL] [Abstract][Full Text] [Related]
4. Role of spinal NO in antiallodynic effect of intrathecal clonidine in neuropathic rats.
Pan HL; Chen SR; Eisenach JC
Anesthesiology; 1998 Dec; 89(6):1518-23. PubMed ID: 9856728
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats.
Chen SR; Pan HL
Anesthesiology; 2003 Dec; 99(6):1409-14. PubMed ID: 14639157
[TBL] [Abstract][Full Text] [Related]
6. Effect of nitric oxide synthase inhibition on tolerance to the analgesic action of D-Pen2, D-Pen5 enkephalin and morphine in the mouse.
Bhargava HN; Zhao GM
Neuropeptides; 1996 Jun; 30(3):219-23. PubMed ID: 8819145
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic administration of [D-Pen2, D-Pen5] enkephalin on the activity of nitric oxide synthase in brain regions and spinal cord of mice.
Bhargava HN; Cao YJ
Peptides; 1998; 19(1):113-7. PubMed ID: 9437743
[TBL] [Abstract][Full Text] [Related]
8. Reduction in [D-Ala2, NMePhe4, Gly-ol5]enkephalin-induced peripheral antinociception in diabetic rats: the role of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway.
Tasatargil A; Sadan G
Anesth Analg; 2004 Jan; 98(1):185-192. PubMed ID: 14693616
[TBL] [Abstract][Full Text] [Related]
9. The effect of intrathecal mu, delta, kappa, and alpha-2 agonists on thermal hyperalgesia induced by mild burn on hind paw in rats.
Kim HJ; Seol TK; Lee HJ; Yaksh TL; Jun JH
J Anesth; 2011 Dec; 25(6):884-91. PubMed ID: 21983967
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of spinal opioid antinociception by intrathecal beta-endorphin1-27 in the rat.
Hong M; Sutak M; Jhamandas K
Br J Pharmacol; 1993 Apr; 108(4):1137-42. PubMed ID: 8485623
[TBL] [Abstract][Full Text] [Related]
11. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
[TBL] [Abstract][Full Text] [Related]
12. Spinal GABAB receptors mediate antinociceptive actions of cholinergic agents in normal and diabetic rats.
Chen SR; Pan HL
Brain Res; 2003 Mar; 965(1-2):67-74. PubMed ID: 12591121
[TBL] [Abstract][Full Text] [Related]
13. Evidence that nitric oxide-glutamate cascade modulates spinal antinociceptive effect of morphine: a behavioural and microdialysis study in rats.
Watanabe C; Okuda K; Sakurada C; Ando R; Sakurada T; Sakurada S
Brain Res; 2003 Nov; 990(1-2):77-86. PubMed ID: 14568332
[TBL] [Abstract][Full Text] [Related]
14. The role of delta-opioid receptor subtypes in neuropathic pain.
Mika J; Przewłocki R; Przewłocka B
Eur J Pharmacol; 2001 Mar; 415(1):31-7. PubMed ID: 11245849
[TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy.
Kiguchi S; Imamura T; Ichikawa K; Kojima M
Clin Exp Pharmacol Physiol; 2004; 31(1-2):57-64. PubMed ID: 14756685
[TBL] [Abstract][Full Text] [Related]
16. The peripheral administration of a nitric oxide donor potentiates the local antinociceptive effects of a DOR agonist during chronic inflammatory pain in mice.
Hervera A; Leánez S; Negrete R; Pol O
Naunyn Schmiedebergs Arch Pharmacol; 2009 Oct; 380(4):345-52. PubMed ID: 19636536
[TBL] [Abstract][Full Text] [Related]
17. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
18. Effects of competitive and noncompetitive antagonists of the N-methyl-D-aspartate receptor on the analgesic action of delta 1- and delta 2-opioid receptor agonists in mice.
Bharagava HN; Zhao GM
Br J Pharmacol; 1996 Dec; 119(8):1586-90. PubMed ID: 8982505
[TBL] [Abstract][Full Text] [Related]
19. Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats.
Zurek JR; Nadeson R; Goodchild CS
Pain; 2001 Feb; 90(1-2):57-63. PubMed ID: 11166970
[TBL] [Abstract][Full Text] [Related]
20. Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of delta-opioid agonists on mechano-nociception.
Chen SR; Pan HL
Neuropharmacology; 2008 Aug; 55(2):215-22. PubMed ID: 18579164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
